SCHEMBL8890437

SCHEMBL8890437

CNC(=O)[C@H]1CC[C@H](CNS(=O)(=O)c2cccc3ccccc23)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 11/20 0.63
NPY1R P25929 4/20 0.60
ALDH1A1 P00352 2/20 0.54
HPGD P15428 2/20 0.54
ADRA2A P08913 1/20 0.54
MAPT P10636 1/20 0.54
AQP1 P29972 1/20 0.54
NPY2R P49146 1/20 0.54
NPY4R P50391 1/20 0.54
MCHR1 Q99705 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
HDAC3 O15379 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52
HDAC11 Q96DB2 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8888802 0.87 NPY5R (0.64) NPY5RNPY1RALDH1A1HPGDADRA2A
SCHEMBL8898918 0.86 NPY5R (0.62) NPY5RNPY1RALDH1A1HPGDADRA2A
SCHEMBL8889955 0.86 NPY5R (0.66) NPY5RNPY1RALDH1A1HPGDADRA2A
SCHEMBL8889950 0.86 NPY5R (0.66) NPY5RNPY1RALDH1A1HPGDADRA2A
SCHEMBL4390192 0.82 NPY5R (0.67) NPY5RNPY1RALDH1A1HPGDADRA2A
SCHEMBL4007555 0.82 NPY5R (0.67) NPY5RNPY1RALDH1A1HPGDADRA2A
SCHEMBL14606719 0.80 NPY5R (0.64) NPY5RNPY1RALDH1A1HPGDADRA2A
SCHEMBL5774740 0.80 NPY5R (0.64) NPY5RNPY1RALDH1A1HPGDADRA2A
SCHEMBL5126972 0.80 NPY5R (0.64) NPY5RNPY1RALDH1A1HPGDADRA2A
SCHEMBL6039411 0.79 ACACB (0.69) NPY5RNPY1RALDH1A1HPGDADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997020823-A2 2-AMINO QUINAZOLINE DERIVATIVES AS NPY RECEPTOR ANTAGONISTS NOVARTIS AG (CH) 1997-06-12 WO disclosed